160 related articles for article (PubMed ID: 26118024)
1. [GOUT AND HYPERTENSION].
Belovol AN; Knyazkova II; Miroshnykova IA
Lik Sprava; 2015; (1-2):32-8. PubMed ID: 26118024
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
Liberopoulos E; Christides D; Elisaf M
J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
[No Abstract] [Full Text] [Related]
3. Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study.
Ueno S; Hamada T; Taniguchi S; Ohtani N; Miyazaki S; Mizuta E; Ohtahara A; Ogino K; Yoshida A; Kuwabara M; Yoshida K; Ninomiya H; Kotake H; Taufiq F; Yamamoto K; Hisatome I
Drug Res (Stuttg); 2016 Dec; 66(12):628-632. PubMed ID: 27643410
[No Abstract] [Full Text] [Related]
4. Hypertension, diuretics, and uric acid.
Reyes AJ; Leary WP
Am J Hypertens; 2006 Oct; 19(10):1093-4. PubMed ID: 17027836
[No Abstract] [Full Text] [Related]
5. Adult hypertension: reducing cardiovascular morbidity and mortality.
Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
[TBL] [Abstract][Full Text] [Related]
6. Hypertension, its treatment, hyperuricaemia and gout.
Gibson TJ
Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
[TBL] [Abstract][Full Text] [Related]
7. Losartan vs. amlodipine treatment in elderly oncologic hypertensive patients: a randomized clinical trial.
Motta M; Russo C; Vacante M; Liardo RL; Reitano F; Cammalleri L; Costanzo M; Benfatto G; Frazzetto P; Mondati E; Malaguarnera M; Pennisi G
Arch Gerontol Geriatr; 2011; 53(1):60-3. PubMed ID: 20569998
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive therapy optimization and endothelial function in patients with gout and chronic urate tubulointerstitial nephritis].
Lebedeva MV; Stakhova TIu; Zaĭtseva LI; Selivanova OIu; Severova MM
Ter Arkh; 2010; 82(6):43-6. PubMed ID: 20731110
[TBL] [Abstract][Full Text] [Related]
9. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.
Lin KC; Lin HY; Chou P
J Rheumatol; 2000 Jun; 27(6):1501-5. PubMed ID: 10852278
[TBL] [Abstract][Full Text] [Related]
10. Gout.
Messerli FH; Makani H; Halpern D
N Engl J Med; 2011 May; 364(19):1876-7; author reply 1877. PubMed ID: 21561363
[No Abstract] [Full Text] [Related]
11. Q: should patients with gout avoid thiazides for hypertension?
Mandell BF
Cleve Clin J Med; 2014 Feb; 81(2):83-6. PubMed ID: 24493485
[No Abstract] [Full Text] [Related]
12. Is uric acid really an independent cardiovascular risk factor?
Beevers DG; Lip GY
Lancet; 1998 Nov; 352(9139):1556. PubMed ID: 9820335
[No Abstract] [Full Text] [Related]
13. [Other antihyperuricemic agents].
Ogino K; Igawa O; Hisatome I
Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
15. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.
Verdecchia P; Schillaci G; Reboldi G; Santeusanio F; Porcellati C; Brunetti P
Hypertension; 2000 Dec; 36(6):1072-8. PubMed ID: 11116127
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
[TBL] [Abstract][Full Text] [Related]
17. [To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering].
MMW Fortschr Med; 2003 Nov; 145(45):51. PubMed ID: 14712789
[No Abstract] [Full Text] [Related]
18. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to specific uric acid lowering treatment in gout in patients with cardiovascular disease.
Ashcroft JA
BMJ; 2018 Sep; 362():k3895. PubMed ID: 30237176
[No Abstract] [Full Text] [Related]
20. Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
Rayner BL; Trinder YA; Baines D; Isaacs S; Opie LH
Am J Hypertens; 2006 Feb; 19(2):208-13. PubMed ID: 16448895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
